Guggenheim Capital LLC Zoetis Inc. Transaction History

Guggenheim Capital LLC

$13.9 Billion
Q2 2024

A detailed history of Guggenheim Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 233,091 shares of ZTS stock, worth $41.7 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

233,091

Previous 233,165 0.03%

Holding current value

$41.7 Million

Previous $39.5 Million 2.42%

% of portfolio

0.29%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $10,769 - $13,233	-74 Reduced 0.03%	233,091 $40.4 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $5.57 Million - $6.72 Million	33,601 Added 16.84%	233,165 $39.5 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $2.85 Million - $3.77 Million	18,831 Added 10.42%	199,564 $39.4 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $5 Million - $5.76 Million	29,890 Added 19.82%	180,733 $31.4 Million
Q2 2023 Aug 11, 2023	BUY	$160.94 - $186.23 $4.14 Million - $4.79 Million	25,698 Added 20.53%	150,843 $26 Million
Q1 2023 May 10, 2023	BUY	$145.48 - $175.02 $4.43 Million - $5.33 Million	30,452 Added 32.16%	125,145 $20.8 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $3.81 Million - $4.57 Million	29,040 Added 44.23%	94,693 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $4.59 Million - $5.65 Million	30,970 Added 89.29%	65,653 $9.74 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $994,152 - $1.28 Million	6,374 Added 22.52%	34,683 $5.96 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $757,303 - $977,075	-4,175 Reduced 12.85%	28,309 $5.34 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $668,036 - $852,006	3,449 Added 11.88%	32,484 $7.93 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $49,783 - $55,148	-263 Reduced 0.9%	29,035 $5.64 Million
Q2 2021 Aug 13, 2021	SELL	$155.9 - $187.99 $3.14 Million - $3.78 Million	-20,116 Reduced 40.71%	29,298 $5.46 Million
Q1 2021 May 13, 2021	SELL	$144.0 - $169.39 $177,408 - $208,688	-1,232 Reduced 2.43%	49,414 $7.78 Million
Q4 2020 Feb 16, 2021	SELL	$157.07 - $174.35 $1.42 Million - $1.57 Million	-9,022 Reduced 15.12%	50,646 $8.38 Million
Q3 2020 Nov 13, 2020	SELL	$137.1 - $165.37 $3.13 Million - $3.78 Million	-22,832 Reduced 27.68%	59,668 $9.87 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $714,721 - $910,196	-6,386 Reduced 7.18%	82,500 $11.3 Million
Q1 2020 Jun 02, 2020	SELL	$92.66 - $144.94 $875,173 - $1.37 Million	-9,445 Reduced 9.61%	88,886 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $2.38 Million - $2.73 Million	20,473 Added 26.3%	98,331 $13 Million
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $4.08 Million - $4.66 Million	-36,271 Reduced 31.78%	77,858 $9.7 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $1.21 Million - $1.41 Million	-12,317 Reduced 9.74%	114,129 $13 Million
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $1.18 Million - $1.46 Million	-14,465 Reduced 10.27%	126,446 $12.7 Million
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $5.02 Million - $6.03 Million	-63,290 Reduced 30.99%	140,911 $12.1 Million
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $3.9 Million - $4.36 Million	46,743 Added 29.69%	204,201 $18.7 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $49 Million - $54.7 Million	-613,684 Reduced 79.58%	157,458 $13.4 Million
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $7.38 Million - $8.74 Million	-103,166 Reduced 11.8%	771,142 $64.4 Million
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $12.6 Million - $14.5 Million	199,200 Added 29.51%	874,308 $63 Million
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $40.3 Million - $44.2 Million	675,108	675,108 $43 Million

Others Institutions Holding ZTS

# of Institutions

1,923

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Zoetis Inc. Transaction History